跳至主要内容
临床试验/CTRI/2020/01/023081
CTRI/2020/01/023081尚未招募3 期

Effect of spironolactone on renal outcome in acute kidney disease: an open label randomised controlled trial

Government of West Bengal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of Acute Kidney Disease, defined as patients with serum creatinine >1.5 times the baseline or egfr <60/ml/min/1.73m2 4weeks after onset of acute kidney injury.

排除标准

  • Patients unable to provide informed or surrogate consent
  • Patients with serum potassium >4.5
  • Females who are pregnant ,lactating or unwilling to use contraception.
  • Patients who are hypotensive with BP < 90/60.
  • Patients with any absolute or relative contraindication for doing renal biopsy.
  • Patients with acute GN diagnosed clinically or by biopsy.
  • Patients with Clinically significant urinary tract obstruction , confirmed by imaging.
  • Patients with history of allergy to spironolactone.
  • Patients with history of any malignancy.

研究者

相似试验